Literature DB >> 15163889

T cells recognize multiple GAD65 and proinsulin epitopes in human type 1 diabetes, suggesting determinant spreading.

Patrick A Ott1, Marcus T Dittrich, Bernhard A Herzog, Robert Guerkov, Peter A Gottlieb, Amy L Putnam, Ivana Durinovic-Bello, Bernhard O Boehm, Magdalena Tary-Lehmann, Paul V Lehmann.   

Abstract

Human type 1 diabetes is thought to be mediated by autoreactive T cells specific for antigens expressed by pancreatic beta cells. However, it is unclear which autoantigens and determinants thereof are the targets of the autoimmune attack. Using comprehensive peptide libraries that cover the entire sequence of two major candidate autoantigens, GAD65 and proinsulin, we measured the in vivo frequencies of peptide-specific, IFN-gamma-producing memory T cells in 27 diabetic patients, 14 high risk individuals, and 15 partially HLA-matched healthy controls. Compared to the controls, both a higher number of determinants on the islet cell antigens were recognized and the frequencies of peptide specific cells were increased in patients and high risk individuals. Inclusion of signal enhancing anti-CD28 antibody further accentuated this difference. Considerable heterogeneity in peptide recognition was seen even in DRB1*04, DQB1*0302 matched individuals. Unlike its peptides, the GAD protein antigen did not recall a T cell memory response. The highly heterogeneous recognition of a multitude of peptide determinants on both autoantigens, occurring in the absence of protein recognition, and the low functional avidity of the memory cells involved jointly suggest that the autoimmune T cell repertoire in human type 1 diabetes primarily targets cryptic determinants engaged by determinant spreading.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15163889     DOI: 10.1023/B:JOCI.0000029120.77824.41

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  49 in total

1.  Characterization of preparations of GAD65, proinsulin, and the islet tyrosine phosphatase IA-2 for use in detection of autoreactive T-cells in type 1 diabetes: report of phase II of the Second International Immunology of Diabetes Society Workshop for Standardization of T-cell assays in type 1 diabetes.

Authors:  M Peakman; T I Tree; J Endl; P van Endert; M A Atkinson; B O Roep
Journal:  Diabetes       Date:  2001-08       Impact factor: 9.461

2.  The Karlsburg type 1 diabetes risk study of a normal schoolchild population: association of beta-cell autoantibodies and human leukocyte antigen-DQB1 alleles in antibody-positive individuals.

Authors:  Michael Schlosser; Martina Strebelow; Ralf Wassmuth; Marie-Luise Arnold; Isabel Breunig; Ilona Rjasanowski; Brigitte Ziegler; Manfred Ziegler
Journal:  J Clin Endocrinol Metab       Date:  2002-05       Impact factor: 5.958

3.  Direct visualization of cytokine-producing recall antigen-specific CD4 memory T cells in healthy individuals and HIV patients.

Authors:  T Helms; B O Boehm; R J Asaad; R P Trezza; P V Lehmann; M Tary-Lehmann
Journal:  J Immunol       Date:  2000-04-01       Impact factor: 5.422

4.  Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays.

Authors:  B O Roep; M A Atkinson; P M van Endert; P A Gottlieb; S B Wilson; J A Sachs
Journal:  J Autoimmun       Date:  1999-09       Impact factor: 7.094

5.  Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice.

Authors:  Siri Atma W Greeley; Makoto Katsumata; Liping Yu; George S Eisenbarth; Daniel J Moore; Heidi Goodarzi; Clyde F Barker; Ali Naji; Hooman Noorchashm
Journal:  Nat Med       Date:  2002-04       Impact factor: 53.440

6.  Maturation of the humoral autoimmune response to epitopes of GAD in preclinical childhood type 1 diabetes.

Authors:  E Bonifacio; V Lampasona; L Bernasconi; A G Ziegler
Journal:  Diabetes       Date:  2000-02       Impact factor: 9.461

7.  Identification and modulation of a naturally processed T cell epitope from the diabetes-associated autoantigen human glutamic acid decarboxylase 65 (hGAD65).

Authors:  G T Nepom; J D Lippolis; F M White; S Masewicz; J A Marto; A Herman; C J Luckey; B Falk; J Shabanowitz; D F Hunt; V H Engelhard; B S Nepom
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

8.  Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes.

Authors:  D L Kaufman; M Clare-Salzler; J Tian; T Forsthuber; G S Ting; P Robinson; M A Atkinson; E E Sercarz; A J Tobin; P V Lehmann
Journal:  Nature       Date:  1993-11-04       Impact factor: 49.962

9.  Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes.

Authors:  J Tian; M A Atkinson; M Clare-Salzler; A Herschenfeld; T Forsthuber; P V Lehmann; D L Kaufman
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

10.  Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells.

Authors:  A Bendelac; C Carnaud; C Boitard; J F Bach
Journal:  J Exp Med       Date:  1987-10-01       Impact factor: 14.307

View more
  15 in total

Review 1.  Molecular mechanisms of T-cell receptor and costimulatory molecule ligation/blockade in autoimmune disease therapy.

Authors:  Joseph R Podojil; Stephen D Miller
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

2.  Detection of GAD65 autoreactive T-cells by HLA class I tetramers in type 1 diabetic patients.

Authors:  Laura Giuliani; Raffaella Mele; Monica Di Giovine; Laura Altieri; Antonino Crinò; Lucilla Ravà; Alessandra Fierabracci
Journal:  J Biomed Biotechnol       Date:  2009-12-08

3.  IFN-gamma and IL-10 islet-antigen-specific T cell responses in autoantibody-negative first-degree relatives of patients with type 1 diabetes.

Authors:  L G Petrich de Marquesini; J Fu; K J Connor; A J Bishop; N E McLintock; C Pope; F S Wong; C M Dayan
Journal:  Diabetologia       Date:  2010-04-06       Impact factor: 10.122

Review 4.  Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease.

Authors:  John P Driver; David V Serreze; Yi-Guang Chen
Journal:  Semin Immunopathol       Date:  2010-04-28       Impact factor: 9.623

5.  H-Y antibody titers are increased in unexplained secondary recurrent miscarriage patients and associated with low male : female ratio in subsequent live births.

Authors:  H S Nielsen; F Wu; Z Aghai; R Steffensen; A G van Halteren; E Spierings; O B Christiansen; D Miklos; E Goulmy
Journal:  Hum Reprod       Date:  2010-09-07       Impact factor: 6.918

6.  Human type 1 diabetes is associated with T cell autoimmunity to zinc transporter 8.

Authors:  MyLinh Dang; Jennifer Rockell; Rebecca Wagner; Janet M Wenzlau; Liping Yu; John C Hutton; Peter A Gottlieb; Howard W Davidson
Journal:  J Immunol       Date:  2011-04-06       Impact factor: 5.422

7.  Disruption of the homeostatic balance between autoaggressive (CD4+CD40+) and regulatory (CD4+CD25+FoxP3+) T cells promotes diabetes.

Authors:  Dan M Waid; Gisela M Vaitaitis; Nathan D Pennock; David H Wagner
Journal:  J Leukoc Biol       Date:  2008-05-09       Impact factor: 4.962

8.  Human CD8 responses to a complete epitope set from preproinsulin: implications for approaches to epitope discovery.

Authors:  Caroline Baker; Liliana G Petrich de Marquesini; Amanda J Bishop; Alan J Hedges; Colin M Dayan; F Susan Wong
Journal:  J Clin Immunol       Date:  2008-02-29       Impact factor: 8.317

Review 9.  Autoreactive T cells in type 1 diabetes.

Authors:  Alberto Pugliese
Journal:  J Clin Invest       Date:  2017-08-01       Impact factor: 14.808

10.  Antigen-based therapy for the treatment of type 1 diabetes.

Authors:  Jide Tian; Daniel L Kaufman
Journal:  Diabetes       Date:  2009-09       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.